Both a higher and lower dose of the extract was shown to reduce appetite and cravings.
A recent study1 found that a bitter hop extract (Amarasate) acts as a GLP-1 activator, reducing appetite and food cravings. Amarasate is the active ingredient in the supplement Calocurb. In the study, 30 adult women fasted for 24 hours on three occasions and given an ad libitum meal to break each fast. As a treatment, participants were given either placebo or two doses of the bitter hop extract (a high dose: 250 mg or low dose: 125 mg). Results showed that both the high and low dose treatment groups experienced significant reductions in appetite and food cravings compared to control.
The researchers note that because of the participants’ fasting, baseline values of hunger were already elevated. So, while appetite suppression was observed, the participants would still be considered hungry. That is to say, the supplement did not remove hunger, just blunted an increase in hunger. Based on previous research, the suppression of hunger from the extract may be related to the inhibition of pro-appetite ghrelin action by stimulating the increase of enteroendocrine cell hormones, which is a potent inhibitor of ghrelin action.
According to the company’s press release, this latest study is the third to validate the ingredient’s benefits, and a fourth is currently underway in 150 men and women. That study will cost $2 million, with results expected in the first half of 2025. The research is supported by funding from the New Zealand government, which has devoted $30 million to the development of a “gut-targeted plant-based nutraceutical for appetite control with Plant and Food Research, a government-owned Crown Research Institute.” They hypothesized that “bitter taste receptors would be found in the gut, due to historical evidence that bitterness modulates appetite.”
Over 1,000 potential candidates were tested, eventually leading to hops, which became the trademarked Amarasate.
Reference
New review paper highlights gut-brain benefits of novel herbal blend, Digexin
September 16th 2024NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.